Sean Lee Analyst Performance

Analyst at HC Wainwright

Sean Lee is a stock analyst at HC Wainwright, covering 11 publicly traded companies across a range of sectors. Over the past year, Sean Lee has issued 19 stock ratings, including strong buy, buy, and hold recommendations. While full access to Sean Lee's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Sean Lee's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rating: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 19 Last 0 Years
Buy Recommendations: 89.47% 17 Buy Ratings
Companies Covered: 11 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	5.3%	1 ratings
Buy	84.2%	16 ratings
Hold	10.5%	2 ratings
Sell	0.0%	0 ratings

Out of 19 total stock ratings issued by Sean Lee at HC Wainwright, the majority (84.2%) have been Buy recommendations, followed by 10.5% Hold and 5.3% Strong Buy.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	81.8% of companies on NASDAQ	9 companies
NYSEAMERICAN	9.1% of companies on NYSEAMERICAN	1 company
NYSE	9.1% of companies on NYSE	1 company

Sean Lee, an analyst at HC Wainwright, currently covers 11 companies listed on NASDAQ, NYSEAMERICAN and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 11 companies	100.0%

Sean Lee of HC Wainwright specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 5 companies	45.5%
MED - DRUGS 2 companies	18.2%
MED PRODUCTS 2 companies	18.2%
PROCESS CONTROL INSTRUMENTS 1 company	9.1%
MED INSTRUMENTS 1 company	9.1%

Time Frame

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
CASI CASI Pharmaceuticals	9/3/2025	Reiterated Rating	$2.30	$4.00	Buy
NVAX Novavax	8/28/2025	Initiated Coverage	$7.58	$10.00	Buy
MYO Myomo	8/12/2025	Lower Price Target	$1.76	$5.00	Buy
KZIA Novogen	7/10/2025	Upgrade	$9.53	$13.00	Strong-Buy
PSTV Plus Therapeutics	6/27/2025	Lower Price Target	$0.37	$3.00	Buy
SENS Senseonics	6/2/2025	Set Price Target	$0.52	$1.10	Buy
CASI CASI Pharmaceuticals	5/19/2025	Reiterated Rating	$1.94	$4.00	Buy
CTSO Cytosorbents	5/15/2025	Reiterated Rating	$0.81	$1.00	Neutral
VSTM Verastem	5/9/2025	Boost Price Target	$6.94	$14.00	Buy
DWTX Dogwood Therapeutics	4/23/2025	Upgrade	$5.46	$10.00	Buy
ATEC Alphatec	4/14/2025	Reiterated Rating	$9.75	$20.00	Buy
CASI CASI Pharmaceuticals	4/9/2025	Lower Price Target	$2.05	$4.00	Buy
CTSO Cytosorbents	4/3/2025	Reiterated Rating	$1.00	$1.00	Neutral
MNPR Monopar Therapeutics	4/1/2025	Reiterated Rating	$36.41	$40.00	Buy
PSTV Plus Therapeutics	3/28/2025	Lower Price Target	$1.52	$5.50	Buy
VSTM Verastem	3/24/2025	Boost Price Target	$6.65	$10.00	Buy
MYO Myomo	3/12/2025	Boost Price Target	$5.87	$9.50	Buy
MNPR Monopar Therapeutics	1/22/2025	Boost Price Target	$31.68	$40.00	Buy
ATEC Alphatec	1/14/2025	Reiterated Rating	$10.88	$20.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.